Preclinical validation of anti‐nuclear factor‐kappa B therapy to inhibit human vestibular schwannoma growth
Open Access
- 31 March 2015
- journal article
- research article
- Published by Wiley in Molecular Oncology
- Vol. 9 (7) , 1359-1370
Abstract
Vestibular schwannomas (VSs), the most common tumors of the cerebellopontine angle, arise from Schwann cells lining the vestibular nerve. Pharmacotherapies against VS are almost non‐existent. Although the therapeutic inhibition of inflammatory modulators has been established for other neoplasms, it has not been explored in VS. A bioinformatic network analysis of all genes reported to be differentially expressed in human VS revealed a pro‐inflammatory transcription factor nuclear factor‐kappa B (NF‐κB) as a central molecule in VS pathobiology. Assessed at the transcriptional and translational level, canonical NF‐κB complex was aberrantly activated in human VS and derived VS cultures in comparison to control nerves and Schwann cells, respectively. Cultured primary VS cells and VS‐derived human cell line HEI‐193 were treated with specific NF‐κB siRNAs, experimental NF‐κB inhibitor BAY11‐7082 (BAY11) and clinically relevant NF‐κB inhibitor curcumin. Healthy human control Schwann cells from the great auricular nerve were also treated with BAY11 and curcumin to assess toxicity. All three treatments significantly reduced proliferation in primary VS cultures and HEI‐193 cells, with siRNA, 5 μM BAY11 and 50 μM curcumin reducing average proliferation (±standard error of mean) to 62.33% ± 10.59%, 14.3 ± 9.7%, and 23.0 ± 20.9% of control primary VS cells, respectively. These treatments also induced substantial cell death. Curcumin, unlike BAY11, also affected primary Schwann cells. This work highlights NF‐κB as a key modulator in VS cell proliferation and survival and demonstrates therapeutic efficacy of directly targeting NF‐κB in VS.Keywords
This publication has 42 references indexed in Scilit:
- Genetic and Epigenetic Alterations of the NF2 Gene in Sporadic Vestibular SchwannomasPLOS ONE, 2012
- miRNA-7 Attenuation in Schwannoma Tumors Stimulates Growth by Upregulating Three Oncogenic Signaling PathwaysCancer Research, 2011
- MicroRNA-21 Overexpression Contributes to Vestibular Schwannoma Cell Proliferation and SurvivalOtology & Neurotology, 2010
- Vestibular Schwannoma Quantitative Polymerase Chain Reaction Expression of Estrogen and Progesterone ReceptorsThe Laryngoscope, 2008
- Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People’s Republic of ChinaJournal of Neuro-Oncology, 2005
- Altered structure and expression of RB1 gene and increased phosphorylation of pRb in human vestibular schwannomasMolecular and Cellular Biochemistry, 2005
- Correlation of Growth Factor Receptor Expression with Clinical Growth in Vestibular SchwannomasOtology & Neurotology, 2004
- Rapid Tumor Formation of Human T-Cell Leukemia Virus Type 1-Infected Cell Lines in Novel NOD-SCID/γcnullMice: Suppression by an Inhibitor against NF-κBJournal of Virology, 2003
- Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2International Journal of Oncology, 2002
- Plasminogen activator activity and molecular weight patterns in human brain tumorsJournal of Neurosurgery, 1988